Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Pharmala Biotech Holdings Inc C.MDMA

Alternate Symbol(s):  MDXXF

PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The Company has three primary business lines... see more

CSE:MDMA - Post Discussion

Pharmala Biotech Holdings Inc > what is with the HUGE increase in
View:
Post by Chefboy69 on Jun 09, 2022 9:38pm

what is with the HUGE increase in

volume on this stock

5x..6x the normal trading volume???

I own this at 0.05 and am connected to someone who knows the CEO

wtf is going on??

because of legal drugs in BC??
that doesn't make any sense???
Comment by Mil_Man54 on Jun 10, 2022 10:17am
Get off the boards Chefboy....you're nothing but a poser who doesn't own a single share in anything....you're just a wannabe who trolls the boards trying to sound important....time to go loser!
Comment by TheMicromalist on Jan 28, 2023 5:48pm
Agreed
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities